Introduction: Candidate selection for cardiothoracic surgery (CTS) training programs is challenging. The recent pandemic has impacted a program's ability to meet matriculants in-person. We hypothesized that a central venue at the CTS annual meeting could prove as a favorable supplement for programs and applicants.
Methods: Surveys were sent to adult cardiothoracic and congenital cardiac surgery training program directors (PD) and department chairs or division chiefs. Separately, surveys were sent to applicants from the 2018 through 2023 electronic residency application service match process.
Results: A total of 166 individuals (PDs and department chairs or division chiefs) were contacted. This represented 94 unique programs, and 45 programs responded. The majority of these programs (88.9%) felt that social gatherings were valuable in evaluating applicants and 86.7% would be interested in a social event at an Society of Thoracic Surgery annual meeting. 54% of applicants did not get an accurate impression of the programs to inform their rank list through virtual interviews, 70% would not be able to accept the same number of interviews in-person versus virtual, and 94% would be interested in attending an annual conference to meet program faculty.
Conclusions: A centralized in-person interview event allows for fiscal and scheduling efficiencies, while creating an opportunity for an equitable exchange between potential candidates and PDs in an efficient manner. Such an event would cost a fraction of what our profession has been incurring, could diversify our workforce, would create early mentoring linkages, and perhaps remodel the way we select trainees.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jss.2024.09.039 | DOI Listing |
Sci Rep
December 2024
Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China.
This study aimed to investigate the safety and effect of omitting chest tubes after thoracoscopic lobectomy in children with congenital lung malformation. A multicenter retrospective study was performed with 632 thoracoscopic lobectomy CLM patients in four hospitals between 2014.1 and 2023.
View Article and Find Full Text PDFMagn Reson Med
December 2024
Department of Radiology, Stanford University School of Medicine, Stanford, California, USA.
Purpose: To measure and validate elevated succinate in brain during circulatory arrest in a piglet model of cardiopulmonary bypass.
Methods: Using data from an archive of 3T H MR spectra acquired in previous in-magnet studies, dynamic plots of succinate, spectral simulations and difference spectra were generated for analysis and validation.
Results: Elevation of succinate during circulatory arrest was observed and validated.
J Surg Oncol
December 2024
Brazilian Society of Surgical Oncology, São Paulo, Brazil.
This document presents guidelines to assist surgeons in the diagnosis and management of this condition, emphasizing a multidisciplinary approach. Recommendations described by a group of physicians members of the Brazilian Society of Oncological Surgery regarding the treatment of neoplastic pericardial effusion, developed to guide oncological surgeons, cardiothoracic surgeons and general surgeons in their clinical practice. Members of the Thoracic Neoplasms Committee carried out a literature review and discussion among expert peers to create a guideline that would help in managing this very serious clinical condition in our oncology practice: Neoplastic pericardial effusion.
View Article and Find Full Text PDFFront Immunol
December 2024
Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Lung cancer remains the primary cause of cancer-related mortality, with factors such as postoperative tumor recurrence, metastasis, and therapeutic drug resistance exacerbating patient outcomes. Immunotherapy has emerged as a transformative approach, challenging conventional treatment paradigms for lung cancer. Consequently, advancing research in lung cancer immunotherapy is imperative.
View Article and Find Full Text PDFFront Immunol
December 2024
Department of Otolaryngology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China.
Background: B-cell receptor-associated protein 31 (BCAP31) is a widely expressed transmembrane protein primarily located in the endoplasmic reticulum (ER), including the ER-mitochondria associated membranes. Emerging evidence suggests that BCAP31 may play a role in cancer development and progression, although its specific effects across different cancer types remain incompletely understood.
Methods: The raw data on BCAP31 expression in tumor and adjacent non-tumor (paracancerous) samples were obtained from the Broad Institute Cancer Cell Line Encyclopedia (CCLE) and UCSC databases.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!